1	NF-kappaB	_	NN	_	_	4	VMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	AP-1	_	NN	_	_	2	CONJ	_	_
4	are	_	VBP	_	_	29	VC	_	_
5	critical	_	JJ	_	_	6	NMOD	_	_
6	regulators	_	NNS	_	_	4	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	inflammatory	_	JJ	_	_	9	NMOD	_	_
9	responses	_	NNS	_	_	7	PMOD	_	_
10	,	_	,	_	_	29	P	_	_
11	proliferation	_	NN	_	_	29	VMOD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	differentiation	_	NN	_	_	12	CONJ	_	_
14	of	_	IN	_	_	11	NMOD	_	_
15	T-cells	_	NNS	_	_	14	PMOD	_	_
16	[	_	(	_	_	11	P	_	_
17	28-30	_	CD	_	_	11	NMOD	_	_
18	]	_	)	_	_	11	P	_	_
19	,	_	,	_	_	29	P	_	_
20	however	_	RB	_	_	29	VMOD	_	_
21	,	_	,	_	_	29	P	_	_
22	the	_	DT	_	_	24	NMOD	_	_
23	signal	_	NN	_	_	24	NMOD	_	_
24	transduction	_	NN	_	_	29	VMOD	_	_
25	and	_	CC	_	_	24	COORD	_	_
26	subsequent	_	JJ	_	_	28	NMOD	_	_
27	cytokine/chemokine	_	NN	_	_	28	NMOD	_	_
28	expression	_	NN	_	_	25	CONJ	_	_
29	is	_	VBZ	_	_	0	ROOT	_	_
30	not	_	RB	_	_	29	VMOD	_	_
31	fully	_	RB	_	_	32	VMOD	_	_
32	understood	_	VBN	_	_	29	VC	_	_
33	.	_	.	_	_	29	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	aim	_	NN	_	_	7	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	present	_	JJ	_	_	6	NMOD	_	_
6	study	_	NN	_	_	3	PMOD	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	to	_	TO	_	_	7	VC	_	_
9	investigate	_	VB	_	_	8	IM	_	_
10	IL-6	_	NN	_	_	13	NMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	CXCL8	_	NN	_	_	11	CONJ	_	_
13	regulation	_	NN	_	_	9	VMOD	_	_
14	by	_	IN	_	_	13	NMOD	_	_
15	NF-kappaB	_	NN	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	AP-1	_	NN	_	_	16	CONJ	_	_
18	in	_	IN	_	_	13	NMOD	_	_
19	Jurkat	_	NN	_	_	20	NMOD	_	_
20	T-cells	_	NNS	_	_	18	PMOD	_	_
21	.	_	.	_	_	7	P	_	_
		
1	Our	_	PRP$	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	demonstrated	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	PMA	_	NN	_	_	6	VMOD	_	_
6	induced	_	VBD	_	_	4	SUB	_	_
7	AP-1	_	NN	_	_	8	NMOD	_	_
8	activation	_	NN	_	_	6	VMOD	_	_
9	,	_	,	_	_	6	P	_	_
10	indicating	_	VBG	_	_	6	VMOD	_	_
11	a	_	DT	_	_	13	NMOD	_	_
12	specific	_	JJ	_	_	13	NMOD	_	_
13	activation	_	NN	_	_	10	VMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	MAPK	_	NN	_	_	17	NMOD	_	_
17	pathway	_	NN	_	_	14	PMOD	_	_
18	.	_	.	_	_	3	P	_	_
		
1	Furthermore	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	we	_	PRP	_	_	4	VMOD	_	_
4	demonstrated	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	PMA	_	NN	_	_	9	NMOD	_	_
7	dependent	_	JJ	_	_	6	AMOD	_	_
8	AP-1	_	NN	_	_	9	NMOD	_	_
9	activation	_	NN	_	_	12	VMOD	_	_
10	in	_	IN	_	_	9	NMOD	_	_
11	T-cells	_	NNS	_	_	10	PMOD	_	_
12	was	_	VBD	_	_	5	SUB	_	_
13	delayed	_	VBN	_	_	12	VC	_	_
14	(	_	(	_	_	17	P	_	_
15	>	_	NN	_	_	17	NMOD	_	_
16	2	_	CD	_	_	17	NMOD	_	_
17	h	_	NN	_	_	13	PRN	_	_
18	)	_	)	_	_	17	P	_	_
19	and	_	CC	_	_	13	COORD	_	_
20	increased	_	VBN	_	_	19	CONJ	_	_
21	following	_	VBG	_	_	20	VMOD	_	_
22	long-term	_	JJ	_	_	23	NMOD	_	_
23	treatment	_	NN	_	_	21	PMOD	_	_
24	.	_	.	_	_	4	P	_	_
		
1	MAPK	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	one	_	CD	_	_	2	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	8	NMOD	_	_
6	main	_	JJ	_	_	8	NMOD	_	_
7	signalling	_	NN	_	_	8	NMOD	_	_
8	pathways	_	NNS	_	_	4	PMOD	_	_
9	in	_	IN	_	_	8	NMOD	_	_
10	T-cells	_	NNS	_	_	9	PMOD	_	_
11	that	_	WDT	_	_	12	VMOD	_	_
12	regulate	_	VBP	_	_	3	NMOD	_	_
13	cell-	_	JJ	_	_	16	NMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	transcriptional	_	JJ	_	_	14	CONJ	_	_
16	activation	_	NN	_	_	12	VMOD	_	_
17	[	_	(	_	_	18	P	_	_
18	31,32	_	CD	_	_	2	PRN	_	_
19	]	_	)	_	_	18	P	_	_
20	.	_	.	_	_	2	P	_	_
		
1	Several	_	JJ	_	_	2	NMOD	_	_
2	studies	_	NNS	_	_	6	VMOD	_	_
3	[	_	(	_	_	4	P	_	_
4	20,33,34	_	NN	_	_	2	PRN	_	_
5	]	_	)	_	_	4	P	_	_
6	have	_	VBP	_	_	0	ROOT	_	_
7	indicated	_	VBN	_	_	6	VC	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	importance	_	NN	_	_	7	VMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	AP-1	_	NN	_	_	10	PMOD	_	_
12	in	_	IN	_	_	9	NMOD	_	_
13	T-cell	_	NN	_	_	14	NMOD	_	_
14	activation	_	NN	_	_	12	PMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	the	_	DT	_	_	17	NMOD	_	_
17	induction	_	NN	_	_	15	CONJ	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	inflammatory	_	JJ	_	_	20	NMOD	_	_
20	responses	_	NNS	_	_	18	PMOD	_	_
21	[	_	(	_	_	22	P	_	_
22	35	_	CD	_	_	20	PRN	_	_
23	]	_	)	_	_	22	P	_	_
24	,	_	,	_	_	20	P	_	_
25	including	_	VBG	_	_	20	NMOD	_	_
26	pro-inflammatory	_	JJ	_	_	28	NMOD	_	_
27	cytokine	_	NN	_	_	28	NMOD	_	_
28	release	_	NN	_	_	25	PMOD	_	_
29	.	_	.	_	_	6	P	_	_
		
1	In	_	IN	_	_	9	VMOD	_	_
2	contrast	_	NN	_	_	1	PMOD	_	_
3	to	_	TO	_	_	2	NMOD	_	_
4	AP-1	_	NN	_	_	3	PMOD	_	_
5	,	_	,	_	_	9	P	_	_
6	NF-kappaB	_	NN	_	_	7	NMOD	_	_
7	activity	_	NN	_	_	9	VMOD	_	_
8	rapidly	_	RB	_	_	9	VMOD	_	_
9	increased	_	VBD	_	_	0	ROOT	_	_
10	(	_	(	_	_	12	P	_	_
11	1	_	CD	_	_	12	NMOD	_	_
12	min	_	NN	_	_	9	PRN	_	_
13	)	_	)	_	_	12	P	_	_
14	during	_	IN	_	_	9	VMOD	_	_
15	PMA	_	NN	_	_	16	NMOD	_	_
16	exposure	_	NN	_	_	14	PMOD	_	_
17	followed	_	VBN	_	_	16	APPO	_	_
18	by	_	IN	_	_	17	VMOD	_	_
19	a	_	DT	_	_	20	NMOD	_	_
20	down-regulation	_	NN	_	_	18	PMOD	_	_
21	to	_	TO	_	_	20	NMOD	_	_
22	the	_	DT	_	_	24	NMOD	_	_
23	lowest	_	JJS	_	_	24	NMOD	_	_
24	levels	_	NNS	_	_	21	PMOD	_	_
25	at	_	IN	_	_	24	NMOD	_	_
26	6	_	CD	_	_	27	NMOD	_	_
27	h	_	NN	_	_	25	PMOD	_	_
28	.	_	.	_	_	9	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	in	_	IN	_	_	2	VMOD	_	_
4	line	_	NN	_	_	3	PMOD	_	_
5	with	_	IN	_	_	4	NMOD	_	_
6	Park	_	NNP	_	_	5	PMOD	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	colleagues	_	NNS	_	_	7	CONJ	_	_
9	[	_	(	_	_	10	P	_	_
10	36	_	CD	_	_	6	PRN	_	_
11	]	_	)	_	_	10	P	_	_
12	who	_	WP	_	_	13	VMOD	_	_
13	demonstrated	_	VBD	_	_	6	NMOD	_	_
14	a	_	DT	_	_	16	NMOD	_	_
15	rapid	_	JJ	_	_	16	NMOD	_	_
16	increase	_	NN	_	_	13	VMOD	_	_
17	in	_	IN	_	_	16	NMOD	_	_
18	NF-kappaB	_	NN	_	_	19	NMOD	_	_
19	activity	_	NN	_	_	17	PMOD	_	_
20	following	_	VBG	_	_	13	VMOD	_	_
21	short-term	_	JJ	_	_	22	NMOD	_	_
22	stimulation	_	NN	_	_	20	PMOD	_	_
23	with	_	IN	_	_	22	NMOD	_	_
24	PMA	_	NN	_	_	23	PMOD	_	_
25	,	_	,	_	_	2	P	_	_
26	but	_	CC	_	_	2	COORD	_	_
27	prolonged	_	JJ	_	_	28	NMOD	_	_
28	challenge	_	NN	_	_	29	VMOD	_	_
29	resulted	_	VBD	_	_	26	CONJ	_	_
30	in	_	IN	_	_	29	VMOD	_	_
31	a	_	DT	_	_	33	NMOD	_	_
32	persistent	_	JJ	_	_	33	NMOD	_	_
33	inhibition	_	NN	_	_	30	PMOD	_	_
34	of	_	IN	_	_	33	NMOD	_	_
35	NF-kappaB	_	NN	_	_	34	PMOD	_	_
36	.	_	.	_	_	2	P	_	_
		
1	They	_	PRP	_	_	2	VMOD	_	_
2	showed	_	VBD	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	inhibition	_	NN	_	_	8	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	NF-kappaB	_	NN	_	_	6	PMOD	_	_
8	was	_	VBD	_	_	3	SUB	_	_
9	due	_	JJ	_	_	8	VMOD	_	_
10	to	_	TO	_	_	9	AMOD	_	_
11	PKC-dependent	_	JJ	_	_	12	NMOD	_	_
12	degradation	_	NN	_	_	10	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	IkappaB	_	NN	_	_	15	NMOD	_	_
15	kinase	_	NN	_	_	13	PMOD	_	_
16	beta	_	NN	_	_	15	NMOD	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	gamma	_	NN	_	_	17	CONJ	_	_
19	in	_	IN	_	_	12	NMOD	_	_
20	response	_	NN	_	_	19	PMOD	_	_
21	to	_	TO	_	_	20	NMOD	_	_
22	PMA	_	NN	_	_	21	PMOD	_	_
23	.	_	.	_	_	2	P	_	_
		
1	Interestingly	_	RB	_	_	8	VMOD	_	_
2	,	_	,	_	_	8	P	_	_
3	the	_	DT	_	_	7	NMOD	_	_
4	HK	_	JJ	_	_	7	NMOD	_	_
5	E.	_	FW	_	_	6	AMOD	_	_
6	coli	_	FW	_	_	7	NMOD	_	_
7	exposure	_	NN	_	_	8	VMOD	_	_
8	induced	_	VBD	_	_	0	ROOT	_	_
9	NF-kappaB	_	NN	_	_	10	NMOD	_	_
10	activation	_	NN	_	_	8	VMOD	_	_
11	without	_	IN	_	_	8	VMOD	_	_
12	affecting	_	VBG	_	_	11	PMOD	_	_
13	AP-1	_	NN	_	_	14	NMOD	_	_
14	activity	_	NN	_	_	12	VMOD	_	_
15	.	_	.	_	_	8	P	_	_
		
1	Wang	_	NNP	_	_	7	VMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	colleagues	_	NNS	_	_	2	CONJ	_	_
4	[	_	(	_	_	5	P	_	_
5	37	_	CD	_	_	1	PRN	_	_
6	]	_	)	_	_	5	P	_	_
7	reported	_	VBD	_	_	0	ROOT	_	_
8	an	_	DT	_	_	11	NMOD	_	_
9	elevated	_	JJ	_	_	11	NMOD	_	_
10	inflammatory	_	JJ	_	_	11	NMOD	_	_
11	response	_	NN	_	_	7	VMOD	_	_
12	by	_	IN	_	_	7	VMOD	_	_
13	obtaining	_	VBG	_	_	12	PMOD	_	_
14	expression	_	NN	_	_	13	VMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	IL-6	_	NN	_	_	15	PMOD	_	_
17	following	_	VBG	_	_	14	NMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	exposure	_	NN	_	_	17	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	T-cells	_	NNS	_	_	20	PMOD	_	_
22	to	_	TO	_	_	19	NMOD	_	_
23	peptidoglycan	_	NN	_	_	22	PMOD	_	_
24	.	_	.	_	_	7	P	_	_
		
1	Reduction	_	NN	_	_	12	VMOD	_	_
2	in	_	IN	_	_	1	NMOD	_	_
3	NF-kappaB	_	NN	_	_	2	PMOD	_	_
4	by	_	IN	_	_	1	NMOD	_	_
5	calcium	_	NN	_	_	6	NMOD	_	_
6	ionophore	_	NN	_	_	4	PMOD	_	_
7	following	_	VBG	_	_	1	NMOD	_	_
8	HK	_	JJ	_	_	11	NMOD	_	_
9	E.	_	FW	_	_	10	AMOD	_	_
10	coli	_	FW	_	_	11	NMOD	_	_
11	stimulation	_	NN	_	_	7	PMOD	_	_
12	may	_	MD	_	_	0	ROOT	_	_
13	be	_	VB	_	_	12	VC	_	_
14	due	_	JJ	_	_	13	VMOD	_	_
15	to	_	TO	_	_	14	AMOD	_	_
16	the	_	DT	_	_	20	NMOD	_	_
17	Ca2+	_	NN	_	_	20	NMOD	_	_
18	binding	_	NN	_	_	20	NMOD	_	_
19	protein	_	NN	_	_	20	NMOD	_	_
20	calmodulin	_	NN	_	_	15	PMOD	_	_
21	(	_	(	_	_	22	P	_	_
22	CaM	_	NN	_	_	20	PRN	_	_
23	)	_	)	_	_	22	P	_	_
24	,	_	,	_	_	20	P	_	_
25	which	_	WDT	_	_	26	VMOD	_	_
26	has	_	VBZ	_	_	20	NMOD	_	_
27	been	_	VBN	_	_	26	VC	_	_
28	shown	_	VBN	_	_	27	VC	_	_
29	to	_	TO	_	_	28	VMOD	_	_
30	negatively	_	RB	_	_	31	VMOD	_	_
31	regulate	_	VB	_	_	29	IM	_	_
32	c-Rel	_	NN	_	_	31	VMOD	_	_
33	when	_	WRB	_	_	34	VMOD	_	_
34	activated	_	VBN	_	_	29	VMOD	_	_
35	[	_	(	_	_	36	P	_	_
36	38	_	CD	_	_	28	PRN	_	_
37	]	_	)	_	_	36	P	_	_
38	.	_	.	_	_	12	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	regulation	_	NN	_	_	12	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	NF-kappaB	_	NN	_	_	3	PMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	AP-1	_	NN	_	_	5	CONJ	_	_
7	observed	_	VBN	_	_	4	APPO	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	present	_	JJ	_	_	11	NMOD	_	_
11	study	_	NN	_	_	8	PMOD	_	_
12	was	_	VBD	_	_	0	ROOT	_	_
13	in	_	IN	_	_	12	VMOD	_	_
14	agreement	_	NN	_	_	13	PMOD	_	_
15	with	_	IN	_	_	14	NMOD	_	_
16	earlier	_	JJR	_	_	17	NMOD	_	_
17	studies	_	NNS	_	_	15	PMOD	_	_
18	.	_	.	_	_	12	P	_	_
		
1	T-cells	_	NNS	_	_	2	VMOD	_	_
2	produce	_	VBP	_	_	0	ROOT	_	_
3	a	_	DT	_	_	5	NMOD	_	_
4	broad	_	JJ	_	_	5	NMOD	_	_
5	range	_	NN	_	_	2	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	pro-	_	JJ	_	_	10	NMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	anti-inflammatory	_	JJ	_	_	8	CONJ	_	_
10	cytokines	_	NNS	_	_	6	PMOD	_	_
11	,	_	,	_	_	10	P	_	_
12	including	_	VBG	_	_	10	NMOD	_	_
13	IL-2	_	NN	_	_	12	PMOD	_	_
14	,	_	,	_	_	13	P	_	_
15	IL-6	_	NN	_	_	13	COORD	_	_
16	,	_	,	_	_	15	P	_	_
17	CXCL8	_	NN	_	_	15	COORD	_	_
18	,	_	,	_	_	17	P	_	_
19	TNF	_	NN	_	_	17	COORD	_	_
20	and	_	CC	_	_	19	COORD	_	_
21	IL-10	_	NN	_	_	20	CONJ	_	_
22	,	_	,	_	_	10	P	_	_
23	in	_	IN	_	_	2	VMOD	_	_
24	response	_	NN	_	_	23	DEP	_	_
25	to	_	TO	_	_	23	DEP	_	_
26	infections	_	NNS	_	_	23	PMOD	_	_
27	or	_	CC	_	_	26	COORD	_	_
28	other	_	JJ	_	_	30	NMOD	_	_
29	stress	_	NN	_	_	30	NMOD	_	_
30	factors	_	NNS	_	_	27	CONJ	_	_
31	[	_	(	_	_	32	P	_	_
32	39	_	CD	_	_	2	PRN	_	_
33	]	_	)	_	_	32	P	_	_
34	.	_	.	_	_	2	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	assessment	_	NN	_	_	12	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	Jurkat	_	NN	_	_	7	NMOD	_	_
5	T-cell	_	NN	_	_	7	NMOD	_	_
6	inflammatory	_	JJ	_	_	7	NMOD	_	_
7	responses	_	NNS	_	_	3	PMOD	_	_
8	(	_	(	_	_	9	P	_	_
9	Table	_	NN	_	_	7	PRN	_	_
10	1	_	CD	_	_	9	NMOD	_	_
11	)	_	)	_	_	9	P	_	_
12	revealed	_	VBD	_	_	0	ROOT	_	_
13	an	_	DT	_	_	16	NMOD	_	_
14	enhanced	_	VBN	_	_	16	NMOD	_	_
15	IL-2	_	NN	_	_	16	NMOD	_	_
16	expression	_	NN	_	_	12	VMOD	_	_
17	upon	_	IN	_	_	16	NMOD	_	_
18	exposure	_	NN	_	_	17	PMOD	_	_
19	to	_	TO	_	_	18	NMOD	_	_
20	PMA	_	NN	_	_	19	PMOD	_	_
21	or	_	CC	_	_	20	COORD	_	_
22	HK	_	NN	_	_	21	CONJ	_	_
23	E.	_	FW	_	_	12	VMOD	_	_
24	coli	_	FW	_	_	23	AMOD	_	_
25	due	_	JJ	_	_	26	DEP	_	_
26	to	_	TO	_	_	12	VMOD	_	_
27	PKC	_	NN	_	_	28	NMOD	_	_
28	activation	_	NN	_	_	26	PMOD	_	_
29	[	_	(	_	_	30	P	_	_
30	40	_	CD	_	_	28	PRN	_	_
31	]	_	)	_	_	30	P	_	_
32	.	_	.	_	_	12	P	_	_
		
1	In	_	IN	_	_	12	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	to	_	TO	_	_	2	NMOD	_	_
4	the	_	DT	_	_	7	NMOD	_	_
5	transcription	_	NN	_	_	7	NMOD	_	_
6	factor	_	NN	_	_	7	NMOD	_	_
7	NF-kappaB	_	NN	_	_	3	PMOD	_	_
8	,	_	,	_	_	12	P	_	_
9	AP-1	_	NN	_	_	11	NMOD	_	_
10	binding	_	NN	_	_	11	NMOD	_	_
11	sites	_	NNS	_	_	12	VMOD	_	_
12	have	_	VBP	_	_	0	ROOT	_	_
13	been	_	VBN	_	_	12	VC	_	_
14	identified	_	VBN	_	_	13	VC	_	_
15	in	_	IN	_	_	14	VMOD	_	_
16	the	_	DT	_	_	19	NMOD	_	_
17	IL-6	_	NN	_	_	19	NMOD	_	_
18	promoter	_	NN	_	_	19	NMOD	_	_
19	region	_	NN	_	_	15	PMOD	_	_
20	,	_	,	_	_	12	P	_	_
21	indicating	_	VBG	_	_	12	VMOD	_	_
22	multiple	_	JJ	_	_	23	NMOD	_	_
23	regulation	_	NN	_	_	21	VMOD	_	_
24	[	_	(	_	_	25	P	_	_
25	22	_	CD	_	_	23	PRN	_	_
26	]	_	)	_	_	25	P	_	_
27	.	_	.	_	_	12	P	_	_
		
1	AP-1	_	NN	_	_	4	VMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	NF-kappaB	_	NN	_	_	2	CONJ	_	_
4	have	_	VBP	_	_	0	ROOT	_	_
5	also	_	RB	_	_	4	VMOD	_	_
6	been	_	VBN	_	_	4	VC	_	_
7	demonstrated	_	VBN	_	_	6	VC	_	_
8	to	_	TO	_	_	7	VMOD	_	_
9	regulate	_	VB	_	_	8	IM	_	_
10	CXCL8	_	NN	_	_	11	NMOD	_	_
11	expression	_	NN	_	_	9	VMOD	_	_
12	during	_	IN	_	_	9	VMOD	_	_
13	induction	_	NN	_	_	12	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	inflammatory	_	JJ	_	_	16	NMOD	_	_
16	responses	_	NNS	_	_	14	PMOD	_	_
17	in	_	IN	_	_	13	NMOD	_	_
18	T-cells	_	NNS	_	_	17	PMOD	_	_
19	[	_	(	_	_	20	P	_	_
20	12	_	CD	_	_	9	PRN	_	_
21	]	_	)	_	_	20	P	_	_
22	.	_	.	_	_	4	P	_	_
		
1	Furthermore	_	RB	_	_	7	VMOD	_	_
2	,	_	,	_	_	7	P	_	_
3	IL-6	_	NN	_	_	6	NMOD	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	CXCL8	_	NN	_	_	4	CONJ	_	_
6	gene-expression	_	NN	_	_	7	VMOD	_	_
7	is	_	VBZ	_	_	0	ROOT	_	_
8	associated	_	VBN	_	_	7	VC	_	_
9	with	_	IN	_	_	8	VMOD	_	_
10	an	_	DT	_	_	13	NMOD	_	_
11	early	_	JJ	_	_	13	NMOD	_	_
12	immune	_	JJ	_	_	13	NMOD	_	_
13	response	_	NN	_	_	9	PMOD	_	_
14	in	_	IN	_	_	13	NMOD	_	_
15	Jurkat	_	NN	_	_	16	NMOD	_	_
16	T-cells	_	NNS	_	_	14	PMOD	_	_
17	[	_	(	_	_	18	P	_	_
18	41	_	CD	_	_	8	PRN	_	_
19	]	_	)	_	_	18	P	_	_
20	.	_	.	_	_	7	P	_	_
		
1	In	_	IN	_	_	12	VMOD	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	present	_	JJ	_	_	4	NMOD	_	_
4	study	_	NN	_	_	1	PMOD	_	_
5	,	_	,	_	_	12	P	_	_
6	both	_	CC	_	_	7	DEP	_	_
7	PMA	_	NN	_	_	12	VMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	HK	_	NN	_	_	8	CONJ	_	_
10	E.	_	FW	_	_	9	NMOD	_	_
11	coli	_	FW	_	_	9	NMOD	_	_
12	resulted	_	VBD	_	_	0	ROOT	_	_
13	in	_	IN	_	_	12	VMOD	_	_
14	comparable	_	JJ	_	_	15	NMOD	_	_
15	increases	_	NNS	_	_	13	PMOD	_	_
16	in	_	IN	_	_	15	NMOD	_	_
17	IL-6	_	NN	_	_	16	PMOD	_	_
18	while	_	IN	_	_	12	VMOD	_	_
19	PMA	_	NN	_	_	20	VMOD	_	_
20	was	_	VBD	_	_	18	SUB	_	_
21	more	_	RBR	_	_	22	AMOD	_	_
22	potent	_	JJ	_	_	20	VMOD	_	_
23	at	_	IN	_	_	22	AMOD	_	_
24	activating	_	VBG	_	_	23	PMOD	_	_
25	CXCL8	_	NN	_	_	26	NMOD	_	_
26	release	_	NN	_	_	24	VMOD	_	_
27	.	_	.	_	_	12	P	_	_
		
1	PMA	_	NN	_	_	8	VMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	HK	_	NN	_	_	6	NMOD	_	_
4	E.	_	FW	_	_	5	AMOD	_	_
5	coli	_	FW	_	_	6	NMOD	_	_
6	treatment	_	NN	_	_	2	CONJ	_	_
7	also	_	RB	_	_	8	VMOD	_	_
8	induced	_	VBD	_	_	0	ROOT	_	_
9	TNF	_	NN	_	_	10	NMOD	_	_
10	expression	_	NN	_	_	8	VMOD	_	_
11	.	_	.	_	_	8	P	_	_
		
1	TNF	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	one	_	CD	_	_	2	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	first	_	JJ	_	_	7	NMOD	_	_
7	cytokines	_	NNS	_	_	4	PMOD	_	_
8	induced	_	VBN	_	_	7	APPO	_	_
9	by	_	IN	_	_	8	VMOD	_	_
10	T-cells	_	NNS	_	_	9	PMOD	_	_
11	[	_	(	_	_	12	P	_	_
12	42	_	CD	_	_	2	PRN	_	_
13	]	_	)	_	_	12	P	_	_
14	and	_	CC	_	_	2	COORD	_	_
15	its	_	PRP$	_	_	16	NMOD	_	_
16	expression	_	NN	_	_	17	VMOD	_	_
17	is	_	VBZ	_	_	14	CONJ	_	_
18	regulated	_	VBN	_	_	17	VC	_	_
19	by	_	IN	_	_	18	VMOD	_	_
20	calcineurin	_	NN	_	_	19	PMOD	_	_
21	,	_	,	_	_	20	P	_	_
22	NFAT	_	NN	_	_	20	COORD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	ATF-2/Jun	_	NN	_	_	23	CONJ	_	_
25	[	_	(	_	_	24	P	_	_
26	20	_	CD	_	_	24	COORD	_	_
27	]	_	)	_	_	20	P	_	_
28	.	_	.	_	_	2	P	_	_
		
1	However	_	RB	_	_	6	VMOD	_	_
2	,	_	,	_	_	6	P	_	_
3	PMA-stimulated	_	JJ	_	_	5	NMOD	_	_
4	Jurkat	_	NN	_	_	5	NMOD	_	_
5	T-cells	_	NNS	_	_	6	VMOD	_	_
6	showed	_	VBD	_	_	0	ROOT	_	_
7	no	_	DT	_	_	8	NMOD	_	_
8	difference	_	NN	_	_	6	VMOD	_	_
9	in	_	IN	_	_	8	NMOD	_	_
10	IL-10	_	NN	_	_	11	NMOD	_	_
11	expression	_	NN	_	_	9	PMOD	_	_
12	indicating	_	VBG	_	_	6	VMOD	_	_
13	an	_	DT	_	_	16	NMOD	_	_
14	induced	_	VBN	_	_	16	NMOD	_	_
15	inflammatory	_	JJ	_	_	16	NMOD	_	_
16	response	_	NN	_	_	12	VMOD	_	_
17	.	_	.	_	_	6	P	_	_
		
1	HK	_	NN	_	_	4	NMOD	_	_
2	E.	_	FW	_	_	3	AMOD	_	_
3	coli	_	FW	_	_	4	NMOD	_	_
4	treatment	_	NN	_	_	5	VMOD	_	_
5	resulted	_	VBD	_	_	0	ROOT	_	_
6	in	_	IN	_	_	5	VMOD	_	_
7	a	_	DT	_	_	9	NMOD	_	_
8	significant	_	JJ	_	_	9	NMOD	_	_
9	reduction	_	NN	_	_	6	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	IL-10	_	NN	_	_	12	NMOD	_	_
12	expression	_	NN	_	_	10	PMOD	_	_
13	.	_	.	_	_	5	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	anti-inflammatory	_	JJ	_	_	4	NMOD	_	_
3	cytokine	_	NN	_	_	4	NMOD	_	_
4	IL-10	_	NN	_	_	5	VMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	known	_	VBN	_	_	5	VC	_	_
7	to	_	TO	_	_	6	VMOD	_	_
8	inhibit	_	VB	_	_	7	IM	_	_
9	T-cell	_	NN	_	_	10	NMOD	_	_
10	activation	_	NN	_	_	8	VMOD	_	_
11	,	_	,	_	_	10	P	_	_
12	proliferation	_	NN	_	_	10	COORD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	expression	_	NN	_	_	13	CONJ	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	pro-inflammatory	_	JJ	_	_	18	NMOD	_	_
18	cytokines	_	NNS	_	_	16	PMOD	_	_
19	,	_	,	_	_	18	P	_	_
20	such	_	JJ	_	_	21	DEP	_	_
21	as	_	IN	_	_	18	NMOD	_	_
22	IL-2	_	NN	_	_	21	PMOD	_	_
23	,	_	,	_	_	22	P	_	_
24	IL-5	_	NN	_	_	22	COORD	_	_
25	and	_	CC	_	_	24	COORD	_	_
26	INF-gamma	_	NN	_	_	25	CONJ	_	_
27	[	_	(	_	_	28	P	_	_
28	39,43	_	NN	_	_	22	PRN	_	_
29	]	_	)	_	_	28	P	_	_
30	and	_	CC	_	_	8	COORD	_	_
31	regulate	_	VB	_	_	30	CONJ	_	_
32	inflammatory	_	JJ	_	_	33	NMOD	_	_
33	responses	_	NNS	_	_	31	VMOD	_	_
34	by	_	IN	_	_	31	VMOD	_	_
35	inducing	_	VBG	_	_	34	PMOD	_	_
36	T-cell	_	NN	_	_	37	NMOD	_	_
37	anergy	_	NN	_	_	35	VMOD	_	_
38	[	_	(	_	_	37	P	_	_
39	44	_	CD	_	_	37	NMOD	_	_
40	]	_	)	_	_	37	P	_	_
41	.	_	.	_	_	5	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	time	_	NN	_	_	3	NMOD	_	_
3	course	_	NN	_	_	4	NMOD	_	_
4	analysis	_	NN	_	_	8	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	cytokine	_	NN	_	_	7	NMOD	_	_
7	expression	_	NN	_	_	5	PMOD	_	_
8	showed	_	VBD	_	_	0	ROOT	_	_
9	a	_	DT	_	_	10	NMOD	_	_
10	correlation	_	NN	_	_	8	VMOD	_	_
11	between	_	IN	_	_	10	NMOD	_	_
12	AP-1	_	NN	_	_	11	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	the	_	DT	_	_	16	NMOD	_	_
15	chemokine	_	NN	_	_	16	NMOD	_	_
16	CXCL8	_	NN	_	_	13	CONJ	_	_
17	where	_	WRB	_	_	20	VMOD	_	_
18	CXCL8	_	NN	_	_	19	NMOD	_	_
19	expression	_	NN	_	_	20	VMOD	_	_
20	was	_	VBD	_	_	16	NMOD	_	_
21	significantly	_	RB	_	_	20	VMOD	_	_
22	elevated	_	VBN	_	_	20	VC	_	_
23	already	_	RB	_	_	22	VMOD	_	_
24	at	_	IN	_	_	22	VMOD	_	_
25	2-6	_	CD	_	_	26	NMOD	_	_
26	h	_	NN	_	_	24	PMOD	_	_
27	after	_	IN	_	_	26	NMOD	_	_
28	PMA	_	NN	_	_	29	NMOD	_	_
29	exposure	_	NN	_	_	27	PMOD	_	_
30	.	_	.	_	_	8	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	CXCL8	_	NN	_	_	3	NMOD	_	_
3	expression	_	NN	_	_	4	VMOD	_	_
4	did	_	VBD	_	_	0	ROOT	_	_
5	not	_	RB	_	_	4	VMOD	_	_
6	correlate	_	VB	_	_	4	VC	_	_
7	with	_	IN	_	_	6	VMOD	_	_
8	the	_	DT	_	_	11	NMOD	_	_
9	early	_	JJ	_	_	11	NMOD	_	_
10	NF-kappaB	_	NN	_	_	11	NMOD	_	_
11	activation	_	NN	_	_	7	PMOD	_	_
12	(	_	(	_	_	14	P	_	_
13	1	_	CD	_	_	14	NMOD	_	_
14	min	_	NN	_	_	11	PRN	_	_
15	)	_	)	_	_	14	P	_	_
16	or	_	CC	_	_	7	COORD	_	_
17	with	_	IN	_	_	16	CONJ	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	down-regulation	_	NN	_	_	17	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	NF-kappaB	_	NN	_	_	20	PMOD	_	_
22	at	_	IN	_	_	19	NMOD	_	_
23	2	_	CD	_	_	24	NMOD	_	_
24	h	_	NN	_	_	22	PMOD	_	_
25	post	_	IN	_	_	24	NMOD	_	_
26	exposure	_	NN	_	_	25	PMOD	_	_
27	.	_	.	_	_	4	P	_	_
		
1	Both	_	CC	_	_	2	DEP	_	_
2	IL-6	_	NN	_	_	6	VMOD	_	_
3	and	_	CC	_	_	2	COORD	_	_
4	TNF	_	NN	_	_	5	NMOD	_	_
5	expression	_	NN	_	_	3	CONJ	_	_
6	were	_	VBD	_	_	0	ROOT	_	_
7	up	_	RB	_	_	6	VMOD	_	_
8	regulated	_	VBN	_	_	6	VC	_	_
9	between	_	IN	_	_	8	VMOD	_	_
10	6-24	_	CD	_	_	11	NMOD	_	_
11	h	_	NN	_	_	9	PMOD	_	_
12	.	_	.	_	_	6	P	_	_
		
1	During	_	IN	_	_	6	VMOD	_	_
2	this	_	DT	_	_	3	NMOD	_	_
3	period	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	6	P	_	_
5	NF-kappaB	_	NN	_	_	6	VMOD	_	_
6	increased	_	VBD	_	_	0	ROOT	_	_
7	from	_	IN	_	_	6	VMOD	_	_
8	its	_	PRP$	_	_	10	NMOD	_	_
9	minimum	_	JJ	_	_	10	NMOD	_	_
10	level	_	NN	_	_	7	PMOD	_	_
11	at	_	IN	_	_	6	VMOD	_	_
12	6	_	CD	_	_	13	NMOD	_	_
13	h	_	NN	_	_	11	PMOD	_	_
14	.	_	.	_	_	6	P	_	_
		
1	PKC	_	NN	_	_	2	VMOD	_	_
2	has	_	VBZ	_	_	0	ROOT	_	_
3	been	_	VBN	_	_	2	VC	_	_
4	shown	_	VBN	_	_	3	VC	_	_
5	to	_	TO	_	_	4	VMOD	_	_
6	be	_	VB	_	_	5	IM	_	_
7	associated	_	VBN	_	_	6	VC	_	_
8	with	_	IN	_	_	7	VMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	activation	_	NN	_	_	8	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	AP-1	_	NN	_	_	11	PMOD	_	_
13	,	_	,	_	_	8	P	_	_
14	but	_	CC	_	_	8	COORD	_	_
15	not	_	RB	_	_	16	DEP	_	_
16	with	_	IN	_	_	14	CONJ	_	_
17	NF-kappaB	_	NN	_	_	18	NMOD	_	_
18	activation	_	NN	_	_	16	PMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	the	_	DT	_	_	22	NMOD	_	_
21	IL-2	_	NN	_	_	22	NMOD	_	_
22	promoter	_	NN	_	_	19	PMOD	_	_
23	[	_	(	_	_	24	P	_	_
24	45	_	CD	_	_	4	PRN	_	_
25	]	_	)	_	_	24	P	_	_
26	.	_	.	_	_	2	P	_	_
		
1	Mutation	_	NN	_	_	6	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	NF-kappaB	_	NN	_	_	5	NMOD	_	_
5	site	_	NN	_	_	2	PMOD	_	_
6	did	_	VBD	_	_	0	ROOT	_	_
7	not	_	RB	_	_	6	VMOD	_	_
8	affect	_	VB	_	_	6	VC	_	_
9	IL-2	_	NN	_	_	10	NMOD	_	_
10	expression	_	NN	_	_	8	VMOD	_	_
11	,	_	,	_	_	8	P	_	_
12	whereas	_	IN	_	_	8	VMOD	_	_
13	mutation	_	NN	_	_	22	VMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	AP-1	_	NN	_	_	17	NMOD	_	_
17	site	_	NN	_	_	14	PMOD	_	_
18	or	_	CC	_	_	13	COORD	_	_
19	PKC	_	NN	_	_	20	NMOD	_	_
20	depletion	_	NN	_	_	18	CONJ	_	_
21	almost	_	RB	_	_	22	VMOD	_	_
22	revoked	_	VBN	_	_	12	SUB	_	_
23	IL-2	_	NN	_	_	24	NMOD	_	_
24	release	_	NN	_	_	22	VMOD	_	_
25	.	_	.	_	_	6	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	observations	_	NNS	_	_	3	VMOD	_	_
3	indicate	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	MAPK	_	NN	_	_	7	NMOD	_	_
7	pathway	_	NN	_	_	13	VMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	the	_	DT	_	_	12	NMOD	_	_
10	transcription	_	NN	_	_	12	NMOD	_	_
11	factor	_	NN	_	_	12	NMOD	_	_
12	AP-1	_	NN	_	_	8	CONJ	_	_
13	play	_	VBP	_	_	4	SUB	_	_
14	an	_	DT	_	_	16	NMOD	_	_
15	important	_	JJ	_	_	16	NMOD	_	_
16	role	_	NN	_	_	13	VMOD	_	_
17	in	_	IN	_	_	13	VMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	induction	_	NN	_	_	17	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	inflammatory	_	JJ	_	_	22	NMOD	_	_
22	responses	_	NNS	_	_	20	PMOD	_	_
23	in	_	IN	_	_	19	NMOD	_	_
24	Jurkat	_	NN	_	_	25	NMOD	_	_
25	T-cells	_	NNS	_	_	23	PMOD	_	_
26	[	_	(	_	_	27	P	_	_
27	12,20,22	_	NN	_	_	25	PRN	_	_
28	]	_	)	_	_	27	P	_	_
29	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	obtained	_	VBN	_	_	3	NMOD	_	_
3	results	_	NNS	_	_	4	VMOD	_	_
4	signify	_	VBP	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	CXCL8	_	NN	_	_	7	VMOD	_	_
7	was	_	VBD	_	_	5	SUB	_	_
8	primarily	_	RB	_	_	7	VMOD	_	_
9	regulated	_	VBN	_	_	7	VC	_	_
10	through	_	IN	_	_	9	VMOD	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	MAPK	_	NN	_	_	13	NMOD	_	_
13	pathway	_	NN	_	_	10	PMOD	_	_
14	.	_	.	_	_	4	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	NF-kappaB	_	NN	_	_	4	NMOD	_	_
3	activation	_	NN	_	_	4	NMOD	_	_
4	inhibitor	_	NN	_	_	8	VMOD	_	_
5	(	_	(	_	_	6	P	_	_
6	NAI	_	NN	_	_	4	PRN	_	_
7	)	_	)	_	_	6	P	_	_
8	showed	_	VBD	_	_	0	ROOT	_	_
9	specificity	_	NN	_	_	8	VMOD	_	_
10	against	_	IN	_	_	8	VMOD	_	_
11	NF-kappaB	_	NN	_	_	10	PMOD	_	_
12	and	_	CC	_	_	8	COORD	_	_
13	resulted	_	VBD	_	_	12	CONJ	_	_
14	in	_	IN	_	_	13	VMOD	_	_
15	a	_	DT	_	_	18	NMOD	_	_
16	complete	_	JJ	_	_	18	NMOD	_	_
17	IL-6	_	NN	_	_	18	NMOD	_	_
18	inhibition	_	NN	_	_	14	PMOD	_	_
19	following	_	VBG	_	_	18	NMOD	_	_
20	induction	_	NN	_	_	19	PMOD	_	_
21	with	_	IN	_	_	20	NMOD	_	_
22	PMA	_	NN	_	_	21	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	significant	_	JJ	_	_	26	NMOD	_	_
25	IL-6	_	NN	_	_	26	NMOD	_	_
26	reduction	_	NN	_	_	23	CONJ	_	_
27	after	_	IN	_	_	20	NMOD	_	_
28	HK	_	JJ	_	_	31	NMOD	_	_
29	E.	_	FW	_	_	30	AMOD	_	_
30	coli	_	FW	_	_	31	NMOD	_	_
31	treatment	_	NN	_	_	27	PMOD	_	_
32	.	_	.	_	_	8	P	_	_
		
1	CXCL8	_	NN	_	_	2	VMOD	_	_
2	was	_	VBD	_	_	0	ROOT	_	_
3	highly	_	RB	_	_	2	VMOD	_	_
4	up	_	RB	_	_	2	VMOD	_	_
5	regulated	_	VBN	_	_	2	VC	_	_
6	by	_	IN	_	_	5	VMOD	_	_
7	PMA	_	NN	_	_	6	PMOD	_	_
8	and	_	CC	_	_	2	COORD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	addition	_	NN	_	_	13	VMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	NAI	_	NN	_	_	11	PMOD	_	_
13	resulted	_	VBD	_	_	8	CONJ	_	_
14	in	_	IN	_	_	13	VMOD	_	_
15	a	_	DT	_	_	17	NMOD	_	_
16	minor	_	JJ	_	_	17	NMOD	_	_
17	reduction	_	NN	_	_	14	PMOD	_	_
18	in	_	IN	_	_	17	NMOD	_	_
19	CXCL8	_	NN	_	_	20	NMOD	_	_
20	expression	_	NN	_	_	18	PMOD	_	_
21	.	_	.	_	_	2	P	_	_
		
1	Furthermore	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	CXCL8	_	NN	_	_	4	NMOD	_	_
4	expression	_	NN	_	_	5	VMOD	_	_
5	was	_	VBD	_	_	0	ROOT	_	_
6	not	_	RB	_	_	5	VMOD	_	_
7	affected	_	VBN	_	_	5	VC	_	_
8	by	_	IN	_	_	7	VMOD	_	_
9	NAI	_	NN	_	_	8	PMOD	_	_
10	following	_	VBG	_	_	7	VMOD	_	_
11	HK	_	JJ	_	_	14	NMOD	_	_
12	E.	_	FW	_	_	13	NMOD	_	_
13	coli	_	FW	_	_	14	NMOD	_	_
14	treatment	_	NN	_	_	10	PMOD	_	_
15	,	_	,	_	_	7	P	_	_
16	indicating	_	VBG	_	_	7	VMOD	_	_
17	a	_	DT	_	_	18	NMOD	_	_
18	lack	_	NN	_	_	16	VMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	correlation	_	NN	_	_	19	PMOD	_	_
21	between	_	IN	_	_	20	NMOD	_	_
22	CXCL8	_	NN	_	_	21	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	NF-kappaB	_	NN	_	_	23	CONJ	_	_
25	.	_	.	_	_	5	P	_	_
		
1	Further	_	JJ	_	_	2	NMOD	_	_
2	analysis	_	NN	_	_	6	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	CXCL8	_	NN	_	_	5	NMOD	_	_
5	expression	_	NN	_	_	3	PMOD	_	_
6	revealed	_	VBD	_	_	0	ROOT	_	_
7	a	_	DT	_	_	8	NMOD	_	_
8	down-regulation	_	NN	_	_	6	VMOD	_	_
9	by	_	IN	_	_	8	NMOD	_	_
10	PKC-	_	NN	_	_	13	NMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	JNK-	_	NN	_	_	11	CONJ	_	_
13	inhibitors	_	NNS	_	_	9	PMOD	_	_
14	,	_	,	_	_	6	P	_	_
15	suggesting	_	VBG	_	_	6	VMOD	_	_
16	an	_	DT	_	_	17	NMOD	_	_
17	involvement	_	NN	_	_	15	VMOD	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	AP-1	_	NN	_	_	18	PMOD	_	_
20	via	_	IN	_	_	15	VMOD	_	_
21	PKC	_	NN	_	_	20	PMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	JNK	_	NN	_	_	22	CONJ	_	_
24	,	_	,	_	_	15	P	_	_
25	respectively	_	RB	_	_	15	VMOD	_	_
26	.	_	.	_	_	6	P	_	_
		
1	Analysis	_	NN	_	_	6	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	gene	_	NN	_	_	4	NMOD	_	_
4	expression	_	NN	_	_	2	PMOD	_	_
5	further	_	RB	_	_	6	VMOD	_	_
6	confirmed	_	VBD	_	_	0	ROOT	_	_
7	that	_	IN	_	_	6	VMOD	_	_
8	il-6	_	NN	_	_	11	VMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	cxcl8	_	NN	_	_	9	CONJ	_	_
11	were	_	VBD	_	_	7	SUB	_	_
12	upregulated	_	VBN	_	_	11	VC	_	_
13	by	_	IN	_	_	12	VMOD	_	_
14	PMA	_	NN	_	_	13	PMOD	_	_
15	.	_	.	_	_	6	P	_	_
		
1	Expression	_	NN	_	_	4	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	il-6	_	NN	_	_	2	PMOD	_	_
4	dropped	_	VBD	_	_	0	ROOT	_	_
5	below	_	IN	_	_	4	VMOD	_	_
6	basal	_	JJ	_	_	7	NMOD	_	_
7	levels	_	NNS	_	_	5	PMOD	_	_
8	following	_	VBG	_	_	4	VMOD	_	_
9	inhibition	_	NN	_	_	8	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	NF-kappaB	_	NN	_	_	10	PMOD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	JNK	_	NN	_	_	12	CONJ	_	_
14	whereas	_	IN	_	_	4	VMOD	_	_
15	cxcl8	_	NN	_	_	16	VMOD	_	_
16	remained	_	VBD	_	_	14	SUB	_	_
17	elevated	_	JJ	_	_	16	VMOD	_	_
18	above	_	IN	_	_	16	VMOD	_	_
19	basal	_	JJ	_	_	20	NMOD	_	_
20	levels	_	NNS	_	_	18	PMOD	_	_
21	(	_	(	_	_	22	P	_	_
22	16.5-fold	_	NN	_	_	20	PRN	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	7.1-fold	_	NN	_	_	23	CONJ	_	_
25	respectively	_	RB	_	_	22	NMOD	_	_
26	)	_	)	_	_	22	P	_	_
27	following	_	VBG	_	_	16	VMOD	_	_
28	the	_	DT	_	_	30	NMOD	_	_
29	same	_	JJ	_	_	30	NMOD	_	_
30	treatment	_	NN	_	_	27	PMOD	_	_
31	.	_	.	_	_	4	P	_	_
		
1	Furthermore	_	RB	_	_	6	VMOD	_	_
2	,	_	,	_	_	6	P	_	_
3	inhibition	_	NN	_	_	6	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	PKC	_	NN	_	_	4	PMOD	_	_
6	did	_	VBD	_	_	0	ROOT	_	_
7	not	_	RB	_	_	6	VMOD	_	_
8	result	_	VB	_	_	6	VC	_	_
9	in	_	IN	_	_	8	VMOD	_	_
10	a	_	DT	_	_	12	NMOD	_	_
11	significant	_	JJ	_	_	12	NMOD	_	_
12	decrease	_	NN	_	_	9	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	il-6	_	NN	_	_	13	PMOD	_	_
15	or	_	CC	_	_	14	COORD	_	_
16	cxcl8	_	NN	_	_	15	CONJ	_	_
17	,	_	,	_	_	12	P	_	_
18	which	_	WDT	_	_	19	VMOD	_	_
19	is	_	VBZ	_	_	12	NMOD	_	_
20	in	_	IN	_	_	19	VMOD	_	_
21	accordance	_	NN	_	_	20	PMOD	_	_
22	with	_	IN	_	_	21	NMOD	_	_
23	protein	_	NN	_	_	24	NMOD	_	_
24	data	_	NNS	_	_	22	PMOD	_	_
25	(	_	(	_	_	26	P	_	_
26	figure	_	NN	_	_	24	PRN	_	_
27	6	_	CD	_	_	26	NMOD	_	_
28	)	_	)	_	_	26	P	_	_
29	.	_	.	_	_	6	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	suggest	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	NF-kappaB	_	NN	_	_	6	VMOD	_	_
6	is	_	VBZ	_	_	4	SUB	_	_
7	involved	_	VBN	_	_	6	VC	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	IL-6	_	NN	_	_	10	NMOD	_	_
10	regulation	_	NN	_	_	8	PMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	release	_	NN	_	_	11	CONJ	_	_
13	while	_	IN	_	_	7	VMOD	_	_
14	it	_	PRP	_	_	15	VMOD	_	_
15	is	_	VBZ	_	_	13	SUB	_	_
16	not	_	RB	_	_	15	VMOD	_	_
17	required	_	VBN	_	_	15	VC	_	_
18	for	_	IN	_	_	17	VMOD	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	expression	_	NN	_	_	18	PMOD	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	CXCL8	_	NN	_	_	21	PMOD	_	_
23	in	_	IN	_	_	20	NMOD	_	_
24	Jurkat	_	NN	_	_	26	NMOD	_	_
25	T	_	NN	_	_	26	NMOD	_	_
26	cells	_	NNS	_	_	23	PMOD	_	_
27	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	transcription	_	NN	_	_	4	NMOD	_	_
3	factor	_	NN	_	_	4	NMOD	_	_
4	NF-kappaB	_	NN	_	_	5	VMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	responsible	_	JJ	_	_	5	VMOD	_	_
7	for	_	IN	_	_	6	AMOD	_	_
8	a	_	DT	_	_	11	NMOD	_	_
9	rapid	_	JJ	_	_	11	NMOD	_	_
10	immune	_	JJ	_	_	11	NMOD	_	_
11	response	_	NN	_	_	7	PMOD	_	_
12	which	_	WDT	_	_	13	VMOD	_	_
13	is	_	VBZ	_	_	11	NMOD	_	_
14	followed	_	VBN	_	_	13	VC	_	_
15	by	_	IN	_	_	14	VMOD	_	_
16	an	_	DT	_	_	17	NMOD	_	_
17	increase	_	NN	_	_	15	PMOD	_	_
18	in	_	IN	_	_	17	NMOD	_	_
19	transcription	_	NN	_	_	18	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	IkappaB	_	NN	_	_	20	PMOD	_	_
22	thus	_	RB	_	_	23	VMOD	_	_
23	inhibiting	_	VBG	_	_	5	VC	_	_
24	NF-kappaB	_	NN	_	_	23	VMOD	_	_
25	[	_	(	_	_	24	P	_	_
26	46	_	CD	_	_	24	NMOD	_	_
27	]	_	)	_	_	24	P	_	_
28	.	_	.	_	_	5	P	_	_
		
1	Activation	_	NN	_	_	7	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	NF-kappaB	_	NN	_	_	2	PMOD	_	_
4	in	_	IN	_	_	1	NMOD	_	_
5	Jurkat	_	NN	_	_	6	NMOD	_	_
6	T-cells	_	NNS	_	_	4	PMOD	_	_
7	is	_	VBZ	_	_	0	ROOT	_	_
8	dependent	_	JJ	_	_	7	VMOD	_	_
9	on	_	IN	_	_	8	AMOD	_	_
10	Bcl10	_	NN	_	_	11	NMOD	_	_
11	activation	_	NN	_	_	9	PMOD	_	_
12	,	_	,	_	_	11	P	_	_
13	which	_	WDT	_	_	16	VMOD	_	_
14	in	_	IN	_	_	16	VMOD	_	_
15	turn	_	NN	_	_	14	PMOD	_	_
16	is	_	VBZ	_	_	11	NMOD	_	_
17	regulated	_	VBN	_	_	16	VC	_	_
18	by	_	IN	_	_	17	VMOD	_	_
19	PKC	_	NN	_	_	18	PMOD	_	_
20	.	_	.	_	_	7	P	_	_
		
1	Recent	_	JJ	_	_	2	NMOD	_	_
2	studies	_	NNS	_	_	3	VMOD	_	_
3	have	_	VBP	_	_	0	ROOT	_	_
4	established	_	VBN	_	_	3	VC	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	importance	_	NN	_	_	4	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	a	_	DT	_	_	10	NMOD	_	_
9	protein	_	NN	_	_	10	NMOD	_	_
10	complex	_	NN	_	_	7	PMOD	_	_
11	consisting	_	VBG	_	_	10	APPO	_	_
12	of	_	IN	_	_	11	VMOD	_	_
13	CARMA1	_	NN	_	_	12	PMOD	_	_
14	,	_	,	_	_	10	P	_	_
15	Bcl10	_	NN	_	_	10	APPO	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	MALT1	_	NN	_	_	16	CONJ	_	_
18	(	_	(	_	_	19	P	_	_
19	CBM	_	NN	_	_	15	PRN	_	_
20	)	_	)	_	_	19	P	_	_
21	,	_	,	_	_	10	P	_	_
22	in	_	IN	_	_	6	NMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	induction	_	NN	_	_	22	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	NF-kappaB	_	NN	_	_	25	PMOD	_	_
27	.	_	.	_	_	3	P	_	_
		
1	Investigating	_	VBG	_	_	10	VMOD	_	_
2	Bcl10	_	NN	_	_	1	VMOD	_	_
3	,	_	,	_	_	10	P	_	_
4	Scharschmidt	_	NNP	_	_	10	VMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	colleagues	_	NNS	_	_	5	CONJ	_	_
7	[	_	(	_	_	8	P	_	_
8	47	_	CD	_	_	4	PRN	_	_
9	]	_	)	_	_	8	P	_	_
10	demonstrated	_	VBD	_	_	0	ROOT	_	_
11	that	_	IN	_	_	10	VMOD	_	_
12	it	_	PRP	_	_	13	VMOD	_	_
13	is	_	VBZ	_	_	11	SUB	_	_
14	a	_	DT	_	_	16	NMOD	_	_
15	critical	_	JJ	_	_	16	NMOD	_	_
16	regulator	_	NN	_	_	13	VMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	NF-kappaB	_	NN	_	_	19	NMOD	_	_
19	activity	_	NN	_	_	17	PMOD	_	_
20	.	_	.	_	_	10	P	_	_
		
1	Down-regulation	_	NN	_	_	12	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	Bcl10	_	NN	_	_	2	PMOD	_	_
4	from	_	IN	_	_	1	NMOD	_	_
5	signals	_	NNS	_	_	4	PMOD	_	_
6	transduced	_	VBN	_	_	5	APPO	_	_
7	via	_	IN	_	_	6	VMOD	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	TCR/CD28	_	NN	_	_	7	PMOD	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	PKC	_	NN	_	_	10	CONJ	_	_
12	resulted	_	VBD	_	_	0	ROOT	_	_
13	in	_	IN	_	_	12	VMOD	_	_
14	a	_	DT	_	_	16	NMOD	_	_
15	concomitant	_	JJ	_	_	16	NMOD	_	_
16	down-regulation	_	NN	_	_	13	PMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	NF-kappaB	_	NN	_	_	17	PMOD	_	_
19	.	_	.	_	_	12	P	_	_
		
1	They	_	PRP	_	_	2	VMOD	_	_
2	suggested	_	VBD	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	Bcl10	_	NN	_	_	5	VMOD	_	_
5	is	_	VBZ	_	_	3	SUB	_	_
6	initially	_	RB	_	_	5	VMOD	_	_
7	activated	_	VBN	_	_	5	VC	_	_
8	by	_	IN	_	_	7	VMOD	_	_
9	TCR/PKC	_	NN	_	_	8	PMOD	_	_
10	but	_	CC	_	_	3	COORD	_	_
11	that	_	IN	_	_	10	CONJ	_	_
12	continued	_	JJ	_	_	13	NMOD	_	_
13	activation	_	NN	_	_	19	VMOD	_	_
14	(	_	(	_	_	17	P	_	_
15	>	_	NN	_	_	17	NMOD	_	_
16	1	_	CD	_	_	17	NMOD	_	_
17	h	_	NN	_	_	13	PRN	_	_
18	)	_	)	_	_	17	P	_	_
19	promotes	_	VBZ	_	_	11	SUB	_	_
20	its	_	PRP$	_	_	21	NMOD	_	_
21	degradation	_	NN	_	_	19	VMOD	_	_
22	.	_	.	_	_	2	P	_	_
		
1	Narayan	_	NNP	_	_	7	VMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	colleagues	_	NNS	_	_	2	CONJ	_	_
4	[	_	(	_	_	5	P	_	_
5	27	_	CD	_	_	1	PRN	_	_
6	]	_	)	_	_	5	P	_	_
7	suggested	_	VBD	_	_	0	ROOT	_	_
8	that	_	IN	_	_	7	VMOD	_	_
9	deletion	_	NN	_	_	18	VMOD	_	_
10	in	_	IN	_	_	9	NMOD	_	_
11	any	_	DT	_	_	10	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	the	_	DT	_	_	17	NMOD	_	_
14	three	_	CD	_	_	17	NMOD	_	_
15	CBM	_	NN	_	_	17	NMOD	_	_
16	complex	_	NN	_	_	17	NMOD	_	_
17	proteins	_	NNS	_	_	12	PMOD	_	_
18	impairs	_	VBZ	_	_	8	SUB	_	_
19	antigen-receptor	_	NN	_	_	21	NMOD	_	_
20	dependent	_	JJ	_	_	19	AMOD	_	_
21	activation	_	NN	_	_	18	VMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	NF-kappaB	_	NN	_	_	22	PMOD	_	_
24	.	_	.	_	_	7	P	_	_
		
1	They	_	PRP	_	_	2	VMOD	_	_
2	showed	_	VBD	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	NF-kappaB	_	NN	_	_	5	NMOD	_	_
5	activation	_	NN	_	_	8	VMOD	_	_
6	via	_	IN	_	_	5	NMOD	_	_
7	Akt	_	NN	_	_	6	PMOD	_	_
8	requires	_	VBZ	_	_	3	SUB	_	_
9	CARMA1	_	NN	_	_	8	VMOD	_	_
10	and	_	CC	_	_	8	COORD	_	_
11	acts	_	VBZ	_	_	10	CONJ	_	_
12	in	_	IN	_	_	11	VMOD	_	_
13	cooperation	_	NN	_	_	12	PMOD	_	_
14	with	_	IN	_	_	13	NMOD	_	_
15	PKC	_	NN	_	_	14	PMOD	_	_
16	following	_	VBG	_	_	13	NMOD	_	_
17	short-term	_	JJ	_	_	18	NMOD	_	_
18	exposure	_	NN	_	_	16	PMOD	_	_
19	(	_	(	_	_	21	P	_	_
20	30	_	CD	_	_	21	NMOD	_	_
21	min	_	NN	_	_	18	PRN	_	_
22	)	_	)	_	_	21	P	_	_
23	of	_	IN	_	_	18	NMOD	_	_
24	Jurkat	_	NN	_	_	25	NMOD	_	_
25	T-cells	_	NNS	_	_	23	PMOD	_	_
26	with	_	IN	_	_	18	NMOD	_	_
27	PMA	_	NN	_	_	26	PMOD	_	_
28	.	_	.	_	_	2	P	_	_
		
1	Akt	_	NN	_	_	2	VMOD	_	_
2	phosphorylates	_	VBZ	_	_	0	ROOT	_	_
3	and	_	CC	_	_	2	COORD	_	_
4	thus	_	RB	_	_	2	VMOD	_	_
5	activates	_	VBZ	_	_	3	CONJ	_	_
6	Bcl10	_	NN	_	_	5	VMOD	_	_
7	.	_	.	_	_	2	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	studies	_	NNS	_	_	3	VMOD	_	_
3	indicate	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	PKC	_	NN	_	_	6	VMOD	_	_
6	is	_	VBZ	_	_	4	SUB	_	_
7	crucial	_	JJ	_	_	6	VMOD	_	_
8	for	_	IN	_	_	7	AMOD	_	_
9	NF-kappaB	_	NN	_	_	10	NMOD	_	_
10	activation	_	NN	_	_	8	PMOD	_	_
11	following	_	VBG	_	_	10	NMOD	_	_
12	short-term	_	JJ	_	_	13	NMOD	_	_
13	treatment	_	NN	_	_	11	PMOD	_	_
14	through	_	IN	_	_	13	NMOD	_	_
15	signals	_	NNS	_	_	14	PMOD	_	_
16	via	_	IN	_	_	15	NMOD	_	_
17	membrane	_	NN	_	_	19	NMOD	_	_
18	bound	_	JJ	_	_	19	NMOD	_	_
19	receptors	_	NNS	_	_	16	PMOD	_	_
20	such	_	JJ	_	_	21	DEP	_	_
21	as	_	IN	_	_	19	NMOD	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	TCR	_	NN	_	_	21	PMOD	_	_
24	and	_	CC	_	_	23	COORD	_	_
25	the	_	DT	_	_	28	NMOD	_	_
26	co-stimulatory	_	JJ	_	_	28	NMOD	_	_
27	receptor	_	NN	_	_	28	NMOD	_	_
28	CD28	_	NN	_	_	24	CONJ	_	_
29	.	_	.	_	_	3	P	_	_
		
1	Thus	_	RB	_	_	7	VMOD	_	_
2	,	_	,	_	_	7	P	_	_
3	the	_	DT	_	_	6	NMOD	_	_
4	CBM	_	NN	_	_	6	NMOD	_	_
5	complex	_	NN	_	_	6	NMOD	_	_
6	proteins	_	NNS	_	_	7	VMOD	_	_
7	play	_	VBP	_	_	0	ROOT	_	_
8	a	_	DT	_	_	10	NMOD	_	_
9	key	_	JJ	_	_	10	NMOD	_	_
10	role	_	NN	_	_	7	VMOD	_	_
11	in	_	IN	_	_	7	VMOD	_	_
12	this	_	DT	_	_	14	NMOD	_	_
13	signalling	_	NN	_	_	14	NMOD	_	_
14	process	_	NN	_	_	11	PMOD	_	_
15	.	_	.	_	_	7	P	_	_
		
1	PMA	_	NN	_	_	2	VMOD	_	_
2	diffuses	_	VBZ	_	_	0	ROOT	_	_
3	into	_	IN	_	_	2	VMOD	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	cytosol	_	NN	_	_	3	PMOD	_	_
6	and	_	CC	_	_	2	COORD	_	_
7	directly	_	RB	_	_	2	VMOD	_	_
8	activates	_	VBZ	_	_	6	CONJ	_	_
9	PKC	_	NN	_	_	8	VMOD	_	_
10	since	_	IN	_	_	8	VMOD	_	_
11	it	_	PRP	_	_	12	VMOD	_	_
12	is	_	VBZ	_	_	10	SUB	_	_
13	an	_	DT	_	_	14	NMOD	_	_
14	analogue	_	NN	_	_	12	VMOD	_	_
15	to	_	TO	_	_	14	NMOD	_	_
16	diacylglycerol	_	NN	_	_	15	PMOD	_	_
17	[	_	(	_	_	16	P	_	_
18	48	_	CD	_	_	16	NMOD	_	_
19	]	_	)	_	_	16	P	_	_
20	.	_	.	_	_	2	P	_	_
		
1	Several	_	JJ	_	_	2	NMOD	_	_
2	studies	_	NNS	_	_	3	VMOD	_	_
3	have	_	VBP	_	_	0	ROOT	_	_
4	demonstrated	_	VBN	_	_	3	VC	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	inhibition	_	NN	_	_	9	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	PKC	_	NN	_	_	7	PMOD	_	_
9	blocks	_	VBZ	_	_	5	SUB	_	_
10	NF-kappaB	_	NN	_	_	13	NMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	AP-1	_	NN	_	_	11	CONJ	_	_
13	activity	_	NN	_	_	9	VMOD	_	_
14	,	_	,	_	_	9	P	_	_
15	suggesting	_	VBG	_	_	9	VMOD	_	_
16	a	_	DT	_	_	18	NMOD	_	_
17	direct	_	JJ	_	_	18	NMOD	_	_
18	regulation	_	NN	_	_	15	VMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	these	_	DT	_	_	22	NMOD	_	_
21	transcription	_	NN	_	_	22	NMOD	_	_
22	factors	_	NNS	_	_	19	PMOD	_	_
23	by	_	IN	_	_	18	NMOD	_	_
24	PKC	_	NN	_	_	23	PMOD	_	_
25	[	_	(	_	_	26	P	_	_
26	49,50	_	NN	_	_	24	PRN	_	_
27	]	_	)	_	_	26	P	_	_
28	.	_	.	_	_	3	P	_	_
		
1	PKC	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	activated	_	VBN	_	_	2	VC	_	_
4	at	_	IN	_	_	3	VMOD	_	_
5	an	_	DT	_	_	7	NMOD	_	_
6	early	_	JJ	_	_	7	NMOD	_	_
7	stage	_	NN	_	_	4	PMOD	_	_
8	following	_	VBG	_	_	3	VMOD	_	_
9	T-cell	_	NN	_	_	10	NMOD	_	_
10	stimulation	_	NN	_	_	8	PMOD	_	_
11	and	_	CC	_	_	2	COORD	_	_
12	is	_	VBZ	_	_	11	CONJ	_	_
13	therefore	_	RB	_	_	12	VMOD	_	_
14	an	_	DT	_	_	16	NMOD	_	_
15	important	_	JJ	_	_	16	NMOD	_	_
16	regulator	_	NN	_	_	12	VMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	downstream	_	JJ	_	_	21	NMOD	_	_
19	inflammatory	_	JJ	_	_	21	NMOD	_	_
20	signalling	_	NN	_	_	21	NMOD	_	_
21	pathways	_	NNS	_	_	17	PMOD	_	_
22	leading	_	VBG	_	_	21	APPO	_	_
23	to	_	TO	_	_	22	VMOD	_	_
24	cytokine	_	NN	_	_	25	NMOD	_	_
25	expression	_	NN	_	_	23	PMOD	_	_
26	[	_	(	_	_	27	P	_	_
27	50	_	CD	_	_	12	PRN	_	_
28	]	_	)	_	_	27	P	_	_
29	.	_	.	_	_	2	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	have	_	VBP	_	_	0	ROOT	_	_
3	shown	_	VBN	_	_	2	VC	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	phosphorylated-PKC	_	NN	_	_	6	VMOD	_	_
6	is	_	VBZ	_	_	4	SUB	_	_
7	up	_	RB	_	_	6	VMOD	_	_
8	regulated	_	VBN	_	_	6	VC	_	_
9	in	_	IN	_	_	8	VMOD	_	_
10	response	_	NN	_	_	9	PMOD	_	_
11	to	_	TO	_	_	10	NMOD	_	_
12	PMA	_	NN	_	_	11	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	HK	_	NN	_	_	13	CONJ	_	_
15	E.	_	FW	_	_	8	VMOD	_	_
16	coli	_	FW	_	_	15	AMOD	_	_
17	,	_	,	_	_	6	P	_	_
18	indicating	_	VBG	_	_	6	VC	_	_
19	an	_	DT	_	_	20	NMOD	_	_
20	association	_	NN	_	_	18	VMOD	_	_
21	between	_	IN	_	_	20	NMOD	_	_
22	PKC	_	NN	_	_	21	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	the	_	DT	_	_	26	NMOD	_	_
25	transcription	_	NN	_	_	26	NMOD	_	_
26	factors	_	NNS	_	_	23	CONJ	_	_
27	AP-1	_	NN	_	_	26	APPO	_	_
28	and	_	CC	_	_	27	COORD	_	_
29	NF-kappaB	_	NN	_	_	28	CONJ	_	_
30	.	_	.	_	_	2	P	_	_
		
1	Bcl10	_	NN	_	_	2	NMOD	_	_
2	levels	_	NNS	_	_	3	VMOD	_	_
3	were	_	VBD	_	_	0	ROOT	_	_
4	down-regulated	_	VBN	_	_	3	VC	_	_
5	following	_	VBG	_	_	4	VMOD	_	_
6	extended	_	JJ	_	_	7	NMOD	_	_
7	treatment	_	NN	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	Jurkat	_	NN	_	_	10	NMOD	_	_
10	T-cells	_	NNS	_	_	8	PMOD	_	_
11	with	_	IN	_	_	7	NMOD	_	_
12	PMA	_	NN	_	_	11	PMOD	_	_
13	.	_	.	_	_	3	P	_	_
		
1	In	_	IN	_	_	10	VMOD	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	control	_	NN	_	_	4	NMOD	_	_
4	groups	_	NNS	_	_	1	PMOD	_	_
5	,	_	,	_	_	10	P	_	_
6	a	_	DT	_	_	7	NMOD	_	_
7	loss	_	NN	_	_	10	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	Bcl10	_	NN	_	_	8	PMOD	_	_
10	occurred	_	VBD	_	_	0	ROOT	_	_
11	after	_	IN	_	_	10	VMOD	_	_
12	6	_	CD	_	_	13	NMOD	_	_
13	h	_	NN	_	_	11	PMOD	_	_
14	,	_	,	_	_	10	P	_	_
15	followed	_	VBN	_	_	10	VMOD	_	_
16	by	_	IN	_	_	15	VMOD	_	_
17	an	_	DT	_	_	18	NMOD	_	_
18	increase	_	NN	_	_	16	PMOD	_	_
19	after	_	IN	_	_	18	NMOD	_	_
20	24	_	CD	_	_	21	NMOD	_	_
21	h	_	NN	_	_	19	PMOD	_	_
22	,	_	,	_	_	18	P	_	_
23	which	_	WDT	_	_	24	VMOD	_	_
24	is	_	VBZ	_	_	18	NMOD	_	_
25	in	_	IN	_	_	24	VMOD	_	_
26	accordance	_	NN	_	_	25	PMOD	_	_
27	with	_	IN	_	_	26	NMOD	_	_
28	the	_	DT	_	_	31	NMOD	_	_
29	observed	_	VBN	_	_	31	NMOD	_	_
30	NF-kappaB	_	NN	_	_	31	NMOD	_	_
31	activity	_	NN	_	_	27	PMOD	_	_
32	(	_	(	_	_	33	P	_	_
33	figure	_	NN	_	_	31	PRN	_	_
34	7	_	CD	_	_	33	NMOD	_	_
35	)	_	)	_	_	33	P	_	_
36	.	_	.	_	_	10	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	are	_	VBP	_	_	0	ROOT	_	_
4	supported	_	VBN	_	_	3	VC	_	_
5	by	_	IN	_	_	4	VMOD	_	_
6	an	_	DT	_	_	8	NMOD	_	_
7	earlier	_	JJR	_	_	8	NMOD	_	_
8	study	_	NN	_	_	5	PMOD	_	_
9	[	_	(	_	_	8	P	_	_
10	47	_	CD	_	_	8	NMOD	_	_
11	]	_	)	_	_	8	P	_	_
12	,	_	,	_	_	8	P	_	_
13	demonstrating	_	VBG	_	_	8	NMOD	_	_
14	that	_	IN	_	_	13	VMOD	_	_
15	prolonged	_	JJ	_	_	17	NMOD	_	_
16	PKC	_	NN	_	_	17	NMOD	_	_
17	activation	_	NN	_	_	20	VMOD	_	_
18	by	_	IN	_	_	17	NMOD	_	_
19	PMA	_	NN	_	_	18	PMOD	_	_
20	leads	_	VBZ	_	_	14	SUB	_	_
21	to	_	TO	_	_	20	VMOD	_	_
22	an	_	DT	_	_	23	NMOD	_	_
23	inhibition	_	NN	_	_	21	PMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	Bcl10	_	NN	_	_	24	PMOD	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	NF-kappaB	_	NN	_	_	26	CONJ	_	_
28	.	_	.	_	_	3	P	_	_
		
1	It	_	PRP	_	_	2	VMOD	_	_
2	has	_	VBZ	_	_	0	ROOT	_	_
3	been	_	VBN	_	_	2	VC	_	_
4	shown	_	VBN	_	_	3	VC	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	NF-kappaB	_	NN	_	_	7	VMOD	_	_
7	is	_	VBZ	_	_	5	SUB	_	_
8	an	_	DT	_	_	11	NMOD	_	_
9	important	_	JJ	_	_	11	NMOD	_	_
10	transcription	_	NN	_	_	11	NMOD	_	_
11	factor	_	NN	_	_	12	NMOD	_	_
12	complex	_	NN	_	_	7	VMOD	_	_
13	involved	_	VBN	_	_	12	APPO	_	_
14	in	_	IN	_	_	13	VMOD	_	_
15	almost	_	RB	_	_	16	AMOD	_	_
16	every	_	DT	_	_	17	NMOD	_	_
17	aspect	_	NN	_	_	14	PMOD	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	cell	_	NN	_	_	20	NMOD	_	_
20	regulation	_	NN	_	_	18	PMOD	_	_
21	including	_	VBG	_	_	17	NMOD	_	_
22	apoptosis	_	NN	_	_	21	PMOD	_	_
23	,	_	,	_	_	22	P	_	_
24	differentiation	_	NN	_	_	22	COORD	_	_
25	,	_	,	_	_	24	P	_	_
26	proliferation	_	NN	_	_	24	COORD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	initiation	_	NN	_	_	27	CONJ	_	_
29	of	_	IN	_	_	22	NMOD	_	_
30	immune	_	JJ	_	_	31	NMOD	_	_
31	responses	_	NNS	_	_	29	PMOD	_	_
32	[	_	(	_	_	33	P	_	_
33	51-53	_	NN	_	_	31	PRN	_	_
34	]	_	)	_	_	33	P	_	_
35	.	_	.	_	_	2	P	_	_
		
1	NF-kappaB	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	constitutively	_	RB	_	_	4	AMOD	_	_
4	active	_	JJ	_	_	2	VMOD	_	_
5	in	_	IN	_	_	4	AMOD	_	_
6	many	_	JJ	_	_	8	NMOD	_	_
7	human	_	JJ	_	_	8	NMOD	_	_
8	malignancies	_	NNS	_	_	5	PMOD	_	_
9	,	_	,	_	_	8	P	_	_
10	which	_	WDT	_	_	11	VMOD	_	_
11	makes	_	VBZ	_	_	8	NMOD	_	_
12	it	_	PRP	_	_	11	VMOD	_	_
13	an	_	DT	_	_	16	NMOD	_	_
14	attractive	_	JJ	_	_	16	NMOD	_	_
15	therapeutic	_	JJ	_	_	16	NMOD	_	_
16	target	_	NN	_	_	11	VMOD	_	_
17	[	_	(	_	_	16	P	_	_
18	54	_	CD	_	_	16	NMOD	_	_
19	]	_	)	_	_	16	P	_	_
20	.	_	.	_	_	2	P	_	_
		
1	Elevated	_	JJ	_	_	3	NMOD	_	_
2	CXCL8	_	NN	_	_	3	NMOD	_	_
3	levels	_	NNS	_	_	7	VMOD	_	_
4	during	_	IN	_	_	3	NMOD	_	_
5	chronic	_	JJ	_	_	6	NMOD	_	_
6	inflammation	_	NN	_	_	4	PMOD	_	_
7	result	_	VBP	_	_	0	ROOT	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	an	_	DT	_	_	11	NMOD	_	_
10	enhanced	_	VBN	_	_	11	NMOD	_	_
11	recruitment	_	NN	_	_	8	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	immune	_	JJ	_	_	14	NMOD	_	_
14	cells	_	NNS	_	_	12	PMOD	_	_
15	to	_	TO	_	_	11	NMOD	_	_
16	the	_	DT	_	_	17	NMOD	_	_
17	site	_	NN	_	_	15	PMOD	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	infection	_	NN	_	_	18	PMOD	_	_
20	,	_	,	_	_	17	P	_	_
21	which	_	WDT	_	_	22	VMOD	_	_
22	may	_	MD	_	_	17	NMOD	_	_
23	lead	_	VB	_	_	22	VC	_	_
24	to	_	TO	_	_	23	VMOD	_	_
25	the	_	DT	_	_	26	NMOD	_	_
26	development	_	NN	_	_	24	PMOD	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	autoimmune	_	JJ	_	_	29	NMOD	_	_
29	diseases	_	NNS	_	_	27	PMOD	_	_
30	following	_	VBG	_	_	26	NMOD	_	_
31	secretion	_	NN	_	_	30	PMOD	_	_
32	of	_	IN	_	_	31	NMOD	_	_
33	pro-inflammatory	_	JJ	_	_	34	NMOD	_	_
34	cytokines	_	NNS	_	_	32	PMOD	_	_
35	.	_	.	_	_	7	P	_	_
		
1	In	_	IN	_	_	0	ROOT	_	_
2	HIV	_	NN	_	_	4	NMOD	_	_
3	infected	_	JJ	_	_	2	AMOD	_	_
4	persons	_	NNS	_	_	1	PMOD	_	_
5	,	_	,	_	_	1	P	_	_
6	serum	_	NN	_	_	8	NMOD	_	_
7	CXCL8	_	NN	_	_	8	NMOD	_	_
8	levels	_	NNS	_	_	9	VMOD	_	_
9	are	_	VBP	_	_	1	COORD	_	_
10	elevated	_	VBN	_	_	9	VC	_	_
11	and	_	CC	_	_	9	COORD	_	_
12	this	_	DT	_	_	13	VMOD	_	_
13	could	_	MD	_	_	11	CONJ	_	_
14	recruit	_	VB	_	_	13	VC	_	_
15	more	_	JJR	_	_	16	NMOD	_	_
16	T-cells	_	NNS	_	_	14	VMOD	_	_
17	potentially	_	RB	_	_	18	VMOD	_	_
18	leading	_	VBG	_	_	14	VMOD	_	_
19	to	_	TO	_	_	18	VMOD	_	_
20	a	_	DT	_	_	23	NMOD	_	_
21	more	_	RBR	_	_	22	AMOD	_	_
22	rapid	_	JJ	_	_	23	NMOD	_	_
23	progression	_	NN	_	_	19	PMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	the	_	DT	_	_	26	NMOD	_	_
26	disease	_	NN	_	_	24	PMOD	_	_
27	since	_	IN	_	_	26	NMOD	_	_
28	there	_	EX	_	_	29	VMOD	_	_
29	will	_	MD	_	_	27	SUB	_	_
30	be	_	VB	_	_	29	VC	_	_
31	more	_	JJR	_	_	32	NMOD	_	_
32	T-cells	_	NNS	_	_	30	VMOD	_	_
33	available	_	JJ	_	_	32	APPO	_	_
34	to	_	TO	_	_	33	AMOD	_	_
35	infect	_	VB	_	_	34	IM	_	_
36	.	_	.	_	_	1	P	_	_
		
